The draft amendment to the Reimbursement Act, submitted to the Standing Committee of the Council of Ministers, did not take into account the comments submitted a year earlier. According to the report from public consultations and the opinions of all stakeholders, the adoption of the regulation would contribute to an increase in the level of patients' subsidies to reimbursed drugs and medical devices and to limit their availability, and would also threaten the continuity of trade in reimbursed products. Enterprises responsible for the production and distribution of drugs and medical devices critically assessed the proposals of the Ministry of Health, reminding them that without the drugs and medical devices for which they are responsible, health care will not function in ...
Content locked
To gain access to the complete English section of the Medexpress.pl, kindly reach out to us at [email protected].
